Skip to content

MDMA: all studies

Page 293 of 345: studies 2,921 to 2,930 of 3,446, newest first. Back to the MDMA overview

Research

Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology

Neurosurgery December 8, 2022 Akanksha Sharma, Shanthi Gowrinathan, Karina Sergi et al. 13 citations

After a decades-long pause, psychedelics are again being intensely investigated for treating a wide range of neuropsychiatric ailments including depression, anxiety, addiction, post-traumatic stress disorder, anorexia, and chronic pain syndromes. The classic serotonergic psychedelics psilocybin and lysergic acid diethylamide and nonclassic psychedelics 3,4-methylenedioxymethamphetamine and...

Psychedelic Drug Legislative Reform and Legalization in the US

JAMA Psychiatry December 7, 2022 Joshua S. Siegel, James E. Daily, Demetrius Perry et al. 168 citations

Importance Psychedelic drugs are becoming accessible in the US through a patchwork of state legislative reforms. This shift necessitates consensus on treatment models, education and guidance for health care professionals, and planning for implementation and regulation. Objective To assess trends in psychedelics legislative reform and legalization in the US to provide guidance to health care...

Psychedelics for treating psychiatric disorders: Are they safe?

Current Psychiatry December 1, 2022 Madonna Thakur 3 citations

SAM FALCONERP sychedelics are a class of substances known to produce alterations in consciousness and perception.In the last 2 decades, psychedelic research has garnered increasing attention from scientists, therapists, entrepreneurs, and the public.While many of these compounds remain illegal in the United States and in many parts of the world (Box, 1 page 16), a recent resurrection of...

4-Isobutylmethcathinone—A Novel Synthetic Cathinone with High In Vitro Cytotoxicity and Strong Receptor Binding Preference of Enantiomers

Pharmaceuticals November 30, 2022 Martin Paškan, Silvie Rimpelová, Vladimíra Svobodová Pavlíčková et al. 9 citations

New psychoactive substances and among them synthetic cathinones represent a significant threat to human health globally. However, within such a large pool of substances derived from a natural compound ((S)-cathinone), substances with important pharmaceutical uses can be identified, as already documented by bupropione. Therefore, this work aimed to find a synthetic pathway for a novel synthetic...

DOI: 10.3390/ph15121495 (opens in new tab) Serotonin Cathinone Cytotoxicity Enantiomer +7

Songs of the Divine: Bhima Bhoi’s Bhajanas and the Spirit of Mahima Dharma

Journal of Humanities,Music and Dance November 26, 2022 Dibya Ranjan Tripathy

This paper delves into the unique blend of spirituality and aesthetics in Bhima Bhoi’s bhajanas, highlighting the almost psychedelic qualities of his poetic language within the context of Mahima Dharma. Bhima Bhoi’s bhajanas are filled with vibrant imagery that pushes beyond the spiritual and cultural limits of his era, illustrating the core values of Mahima Dharma—such as monotheism,...

Recumbent Journeys Into Sound—Music, Imagery, and Altering States of Consciousness

November 10, 2022 Jörg Fachner 2 citations

The Bonny Method of Guided Imagery and Music (GIM) has evolved out of a pharmaco-supported psychotherapy setting in which the Altered State of Consciousness (ASC) has been evoked with strong psychedelic drugs. However, Helen Bonny observed that inducing an ASC with deep relaxation methods and a subsequent journey in a reclined or supine position elicited sufficient imagery for the therapy...

DOI: 10.4324/9780429330070-21 (opens in new tab) Guided imagery Mental image Consciousness Altered state +3

Complexities of psychedelics for therapeutic use in obesity and eating disorders

Journal of Psychiatry and Neuroscience October 25, 2022 A. Reichelt

In an interesting and timely editorial, Borgland and Neyens provide a snap­ shot of preclinical research that could support the development of psyche­ delic drugs as part of a therapeutic regimen in individuals with obesity or eating disorders (EDs), including an­ orexia nervosa (AN) and binge eating disorder (BED).1 The role of the sero­ tonergic system in appetite was key in the development...

Preparing for psychedelic therapies in Australia

October 18, 2022 Paul Liknaitzky

Psychedelic therapies have the potential to treat mental illness but there’s still a long way to go. After decades in the wilderness, psychedelic therapies are making a comeback into clinical research and are poised to re-enter medical care. When used alongside psychotherapy, drugs like psilocybin (found in ‘magic mushrooms’) and MDMA (found in ‘ecstasy’) have […]

Club drugs: Um Novo Perfil de Abuso de Substâncias em Adolescentes e Jovens Adultos.

Acta Médica Portuguesa October 5, 2022 Diogo Frasquilho Guerreiro, Ana Lisa Carmo, Joaquim Alves da Silva et al. 2 citations

Club drugs are the following substances: Methylenedioxymethamphetamine (MDMA); Methamphetamine; Lysergic Acid Diethylamide (LSD); Ketamine; Gamma-hydroxybutyrate (GHB) and Flunitrazepam. These substances are mainly used by adolescents and young adults, mostly in recreational settings like dance clubs and rave parties. These drugs have diverse psychotropic effects, are associated with several...

Hope that psychedelic drugs can erase trauma

Nature September 29, 2022 Lauren Gravitz 3 citations

Some researchers are finding clues that MDMA might be able to treat post-traumatic stress disorder. But the science has yet to catch up with the optimism. Some researchers are finding clues that MDMA might be able to treat post-traumatic stress disorder. But the science has yet to catch up with the optimism.